Shree Pacetronix Quarterly Results for Trading Insights
SHREEPAC • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QSept 2025
Shree Pacetronix Quarterly Results Key Highlights
- Revenue of ₹7 Cr in Sept 2025 (+75.0% vs Mar 2025, +75.0% vs Sept 2024)
- Net Profit of ₹1 Cr in Sept 2025
- EBITDA of ₹2 Cr in Sept 2025 (+100.0% vs Mar 2025)
- Operating Margin of 31.0% in Sept 2025 (+8.0pp vs Mar 2025)
- Earnings Per Share of ₹3.64 in Sept 2025 (+188.9% vs Mar 2025)
Shree Pacetronix Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 7 | 4 | 5 | 4 | 4 | 75.0% | 75.0% |
| Net Profit (₹ Cr) | 1 | 0 | 1 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 2 | 1 | 1 | 0 | 0 | - | - |
| EPS (₹) | 3.64 | 1.26 | 1.85 | 0.16 | 0.09 | - | - |
| Operating Margin (%) | 31.0% | 23.0% | 22.0% | 10.0% | 10.0% | - | - |
Shree Pacetronix Share Price Trend Around Quarterly Results
Visualize Shree Pacetronix's 1-year price movement across quarterly results — ideal for logging trades in Shree Pacetronix share price
chart using Tickjournal. All values in ₹.
Related Pages for Shree Pacetronix
Additional stock information and data for SHREEPAC
Revenue Trend (₹ Cr)
Dec 2025
4
Jun 2025
5
Mar 2025
4
Sept 2025
7
Net Profit Trend (₹ Cr)
Dec 2025
0
Jun 2025
1
Mar 2025
0
Sept 2025
1
Operating Margin Trend (%)
Dec 2025
10.0%
Jun 2025
22.0%
Mar 2025
23.0%
Sept 2025
31.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Shree Pacetronix quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1807.4 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.0 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6330.0 | 2,860 | 689 | +7.1% | - | 24.1% | 243.7 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4373.7 | 3,219 | 591 | +11.3% | - | 18.4% | 249.4 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1325.0 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.2 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1287.0 | 9,135 | 1,337 | +1.1% | - | 14.6% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores